JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SABS - Sab Biotherapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SABS Stock
Financials
Financials SABS Stock
Loading...
Loading...
Income Statement
Income Statement SABS Stock
Balance Sheet
Balance Sheet SABS Stock
Cash Flow Statement
Cash Flow Statement SABS Stock
Loading...
Loading...
Home
Stocks
Sab Biotherapeutics, Inc. (SABS)
Financials
Financials of SABS
Loading...
Loading...
Loading...
Loading...
SABS Financials - Sab Biotherapeutics Income & Cash Flow | Ledgeburg
Revenue
$0
Operating Income
$-48.953363M
Net Income
$13.273683M
Share Count (Basic)
19.311798M
Operating Cash Flow
$-44.775111M
Free Cash Flow
$-45.708267M
Cash And Short-Term Equivalents
$96.592459M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-40M
-20M
0
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-3000%
-2000%
-1000%
0%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-20M
0
20M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available